Daniel Bradbury - Net Worth and Insider Trading
Daniel Bradbury Net Worth
The estimated net worth of Daniel Bradbury is at least $10 Million dollars as of 2024-08-26. Daniel Bradbury is the Director of Corcept Therapeutics Inc and owns about 177,925 shares of Corcept Therapeutics Inc (CORT) stock worth over $6 Million. Daniel Bradbury is the Director of Illumina Inc and owns about 15,324 shares of Illumina Inc (ILMN) stock worth over $2 Million. Daniel Bradbury is also the Director of Castle Biosciences Inc and owns about 60,493 shares of Castle Biosciences Inc (CSTL) stock worth over $2 Million. Besides these, Daniel Bradbury also holds Intercept Pharmaceuticals Inc (ICPT) . Details can be seen in Daniel Bradbury's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Daniel Bradbury has not made any transactions after 2024-08-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Daniel Bradbury
Daniel Bradbury Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Daniel Bradbury owns 10 companies in total, including Castle Biosciences Inc (CSTL) , Panacea Acquisition Corp (PANA.U) , and Intercept Pharmaceuticals Inc (ICPT) among others .
Click here to see the complete history of Daniel Bradbury’s form 4 insider trades.
Insider Ownership Summary of Daniel Bradbury
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
CSTL | Castle Biosciences Inc | 2024-08-12 | director |
PANA.U | Panacea Acquisition Corp | 2020-06-30 | director |
ICPT | Intercept Pharmaceuticals Inc | 2020-05-28 | director |
![]() | ![]() | 2018-10-11 | director & Chief Executive Officer |
![]() | ![]() | 2012-09-26 | director |
![]() | ![]() | 2016-07-21 | director |
![]() | ![]() | 2017-05-25 | director |
![]() | ![]() | 2016-01-27 | director |
![]() | ![]() | 2006-05-09 | director |
![]() | ![]() | 2020-06-30 | director |
Daniel Bradbury Latest Holdings Summary
Daniel Bradbury currently owns a total of 4 stocks. Among these stocks, Daniel Bradbury owns 177,925 shares of Corcept Therapeutics Inc (CORT) as of December 10, 2015, with a value of $6 Million and a weighting of 61.1%. Daniel Bradbury owns 15,324 shares of Illumina Inc (ILMN) as of May 25, 2017, with a value of $2 Million and a weighting of 19.61%. Daniel Bradbury also owns 60,493 shares of Castle Biosciences Inc (CSTL) as of August 12, 2024, with a value of $2 Million and a weighting of 17.12%. The other 1 stocks Intercept Pharmaceuticals Inc (ICPT) have a combined weighting of 2.17% among all his current holdings.
Latest Holdings of Daniel Bradbury
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
CORT | Corcept Therapeutics Inc | 2015-12-10 | 177,925 | 35.00 | 6,227,375 |
ILMN | Illumina Inc | 2017-05-25 | 15,324 | 130.42 | 1,998,556 |
CSTL | Castle Biosciences Inc | 2024-08-12 | 60,493 | 28.85 | 1,745,223 |
ICPT | Intercept Pharmaceuticals Inc | 2018-04-09 | 11,642 | 19.00 | 221,198 |
Holding Weightings of Daniel Bradbury
Daniel Bradbury Form 4 Trading Tracker
According to the SEC Form 4 filings, Daniel Bradbury has made a total of 0 transactions in Corcept Therapeutics Inc (CORT) over the past 5 years. The most-recent trade in Corcept Therapeutics Inc is the sale of 20,000 shares on December 10, 2015, which brought Daniel Bradbury around $97,000.
According to the SEC Form 4 filings, Daniel Bradbury has made a total of 0 transactions in Illumina Inc (ILMN) over the past 5 years. The most-recent trade in Illumina Inc is the sale of 600 shares on May 25, 2017, which brought Daniel Bradbury around $104,166.
According to the SEC Form 4 filings, Daniel Bradbury has made a total of 70 transactions in Castle Biosciences Inc (CSTL) over the past 5 years, including 0 buys and 70 sells. The most-recent trade in Castle Biosciences Inc is the sale of 7,883 shares on August 12, 2024, which brought Daniel Bradbury around $210,082.
More details on Daniel Bradbury's insider transactions can be found in the Insider Trading History of Daniel Bradbury table.Insider Trading History of Daniel Bradbury
- 1
Daniel Bradbury Trading Performance
GuruFocus tracks the stock performance after each of Daniel Bradbury's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Daniel Bradbury is 34.02%. GuruFocus also compares Daniel Bradbury's trading performance to market benchmark return within the same time period. The performance of stocks bought by Daniel Bradbury within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Daniel Bradbury's insider trading performs compared to the benchmark.
Performance of Daniel Bradbury
Daniel Bradbury Ownership Network
Ownership Network List of Daniel Bradbury
Ownership Network Relation of Daniel Bradbury
![Insider Network Chart](https://static.gurufocus.com/insider-network.png)
Daniel Bradbury Owned Company Details
What does Castle Biosciences Inc do?
Who are the key executives at Castle Biosciences Inc?
Daniel Bradbury is the director of Castle Biosciences Inc. Other key executives at Castle Biosciences Inc include Chief Financial Officer Frank Stokes , Chief Operating Officer Kristen M Oelschlager , and director & 10 percent owner & Pres. & Chief Exec. Officer Derek J Maetzold .
Castle Biosciences Inc (CSTL) Insider Trades Summary
Over the past 18 months, Daniel Bradbury made 22 insider transaction in Castle Biosciences Inc (CSTL) with a net sale of 322,922. Other recent insider transactions involving Castle Biosciences Inc (CSTL) include a net sale of 272,861 shares made by Derek J Maetzold , a net sale of 18,575 shares made by Kristen M Oelschlager , and a net sale of 10,000 shares made by Frank Stokes .
In summary, during the past 3 months, insiders sold 42,794 shares of Castle Biosciences Inc (CSTL) in total and bought 0 shares, with a net sale of 42,794 shares. During the past 18 months, 624,358 shares of Castle Biosciences Inc (CSTL) were sold and 4,800 shares were bought by its insiders, resulting in a net sale of 619,558 shares.
Castle Biosciences Inc (CSTL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Castle Biosciences Inc Insider Transactions
Daniel Bradbury Mailing Address
Above is the net worth, insider trading, and ownership report for Daniel Bradbury. You might contact Daniel Bradbury via mailing address: Biobrit, Llc, 2223 Avenida De La Playa, Suite 108, La Jolla Ca 92037.